{'output': [['Ablynx NV', 'ORG', 'Has', 'Board', 'ORG/GOV'], ['Board', 'ORG/GOV', 'Conclude', None, None], ['Proposal', None, 'Undervalue', 'Ablynx NV', 'ORG'], ['Ablynx NV', 'ORG', 'Have', 'Strong Prospects', 'CONCEPT'], ['Ablynx NV', 'ORG', 'Have', 'Continued Growth', 'CONCEPT'], ['Ablynx NV', 'ORG', 'Have', 'Value Creation', 'CONCEPT'], ['Ablynx NV', 'ORG', 'Receive', 'Proposal', None], ['Proposal', None, 'From', 'Novo Nordisk A/S', 'ORG'], ['Ablynx NV', 'ORG', 'Has', 'J.P. Morgan', 'COMP'], ['J.P. Morgan', 'COMP', 'Serve', None, 'None'], ['Ablynx NV', 'ORG', 'Believe', None, None], ['Proposal', None, 'Undervalue', 'Company', None], ['Ablynx NV', 'ORG', 'Have', 'Long-term Strategic Plan', 'CONCEPT'], ['Plan', None, 'Of', 'Becoming', None], ['Ablynx NV', 'ORG', 'Be', 'Fully Integrated Biopharmaceutical Company', 'COMP'], ['Board', 'ORG/GOV', 'See', 'No Merit', 'CONCEPT'], ['Ceding Control', None, 'Of', 'Assets', None], ['Assets', None, 'Without', 'Full Upfront Value Recognition', 'CONCEPT'], ['Recognition', None, 'For', 'Shareholders', 'PERSON']]}